Effects of Walking and Heating on Vascular Function in Diabetic Patients
NCT ID: NCT03203694
Last Updated: 2024-04-04
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
99 participants
INTERVENTIONAL
2017-12-04
2022-03-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Heat Therapy and Strength Training Effects in Individuals With Type 2 Diabetes
NCT05847075
Heat and Exercise in Aging as Therapy (HEAT)
NCT06580964
The Effect of Walking Meditation Training on Glycemic Control and Vascular Function in Patients With Type 2 Diabetes
NCT02123901
Role of Interrupting Sedentary Time in Management of Type-2 Diabetes
NCT02738996
The Effects of Altering Physical Activity on Cardiometabolic Health
NCT01879059
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Walking: Intervention arm in diabetics
The walking program will consist of 45 minutes of walking (at a moderate pace) 5 days per week for 8 weeks.
Walking: Intervention arm in diabetics
The walking program will consist of 45 minutes of walking (at a moderate pace) 5 days per week for 8 weeks.
Walking: No intervention in diabetics
Subjects will be instructed to continue their usual lifestyle for 8 weeks.
Walking: No intervention in diabetics
Subjects will be instructed to continue their usual lifestyle for 8 weeks.
Walking: Healthy cohort as reference controls
Subjects will be studied at one time only.
Walking: Healthy cohort as reference controls
Subjects will be studied at one time only.
Lower body heating: Intervention arm in healthy subjects
This intervention consists of 60 minutes of lower body heating (40-42 degree C).
Lower body heating: Intervention arm in healthy subjects
This intervention consists of 60 minutes of lower body heating (40-42 degree C).
Lower body heating: Intervention arm in diabetics
This intervention consists of 60 minutes of lower body heating (40-42 degree C) 7 days per week for 7 days.
Lower body heating: Intervention arm in diabetics
This intervention consists of 60 minutes of lower body heating (40-42 degree C) 7 days per week for 7 days.
Lower body heating: Healthy cohort as reference controls
Subjects will be studied at one time only.
Lower body heating: Healthy cohort as reference controls
Subjects will be studied at one time only.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Walking: Intervention arm in diabetics
The walking program will consist of 45 minutes of walking (at a moderate pace) 5 days per week for 8 weeks.
Walking: No intervention in diabetics
Subjects will be instructed to continue their usual lifestyle for 8 weeks.
Walking: Healthy cohort as reference controls
Subjects will be studied at one time only.
Lower body heating: Intervention arm in healthy subjects
This intervention consists of 60 minutes of lower body heating (40-42 degree C).
Lower body heating: Intervention arm in diabetics
This intervention consists of 60 minutes of lower body heating (40-42 degree C) 7 days per week for 7 days.
Lower body heating: Healthy cohort as reference controls
Subjects will be studied at one time only.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. renal or hepatic diseases;
3. active cancer;
4. autoimmune diseases;
5. immunosuppressant therapy;
6. excessive alcohol consumption (\>14 drinks/week for men; \>7 drinks/week for women);
7. current tobacco use;
8. pregnancy;
9. mobility limitations;
10. foot ulcers;
11. diabetic neuropathy
12. uncontrolled hypertension (\>=180 systolic / 100 diastolic mmHg)
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Missouri-Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jaume Padilla
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jaume Padilla, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Missouri-Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Missouri
Columbia, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Document Type: Informed Consent Form: Lower body heating
Document Type: Informed Consent Form: Lower body heating: Healthy cohort as reference controls
Document Type: Informed Consent Form: Walking
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008181
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.